Search Results
Jul 14, 2026, 19:30 ET Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint
therapeutic bottleneck.Following the meeting of the primary endpoint in the Phase III OptiTROP-Lung05 study for first-line PD-L1-positive NSCLC, the positive results were achieved in another Phase III trial of sac-TMT plus pembrolizumab, providing robust clinical evidence supporting the expansion
More news about: Kelun-Biotech
Jul 14, 2026, 16:30 ET Leica Biosystems to Acquire StatLab
as to the timing of the Transaction; (ii) the risk that the Transaction may not be completed on the anticipated terms in a timely manner or at all; (iii) the failure to satisfy any of the conditions to the consummation of the Transaction; (iv) the possibility that any or all of the various conditions
More news about: Leica Biosystems
Jul 14, 2026, 16:30 ET Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test
into inflammatory skin disease, (ii) help clinicians select treatments that can improve patient outcomes and reduce unnecessary treatment cycling, (iii) transform how moderate-to-severe AD is managed, (iv) enable biology-informed treatment decisions and (v) help patients achieve meaningful relief from
More news about: Castle Biosciences, Inc.
Jul 14, 2026, 15:00 ET Apple Tree Partners Provides Update Following Recent Cayman Court Order
including partnerships and other transactions. ATP III GP Ltd, controlled by Seth Harrison, remains in Chapter 11, and the US Bankruptcy Court recently ordered that any changes to ATP portfolio company boards or senior management must be approved by ATP III GP Ltd.ATP has made a funding motion to
More news about: Apple Tree Partners
Jul 14, 2026, 14:10 ET Pavlus Travel & Cruise Posts Strong Luxury Travel Results, Identifies Emerging Travel Trends for 2027 Vacations
many future cruise sales resulted from that. Clients are also inquiring about a future vacation on such new ships as Explora Journeys' Explora III and Regent Seven Seas Cruises' Seven Seas Prestige, both launching this year, and Four Seasons Yachts' Four Seasons II, debuting in 2028,
More news about: Pavlus Travel & Cruise, Inc.
Jul 14, 2026, 11:00 ET PITTCO ADDS GRANT SELF AS ANALYST, INVESTMENTS
with a minor in Sports Administration.ABOUT PITTCO MANAGEMENT, LLCPittco is the single-family office for Joseph R. "Pitt" Hyde III, founder of AutoZone, and his wife, Barbara. Pittco was established over 30 years ago, and provides investment, accounting, tax, and financial services
More news about: Pittco Management, LLC
Jul 14, 2026, 10:31 ET Alport Syndrome Market to Grow at a Tremendous 47% CAGR Through 2036, Driven by Emerging Therapies and Expanding Clinical Pipeline | DelveInsight
Alport syndrome.In January 2026, ENYO Pharma targets an End-of-Phase II meeting in Q2 2026, ahead of the planned initiation of the Phase III alport syndrome study in 2H 2026.Alport Syndrome Epidemiology SegmentationThe Alport syndrome epidemiology section provides
More news about: DelveInsight Business Research, LLP
Jul 14, 2026, 10:23 ET Republic of Honduras Announces Offer to Purchase Existing Notes
extend the period of time during which the Offer shall remain open at any time and from time to time, (ii) terminate or withdraw the Offer at any time, (iii) amend the terms of the Offer in any respect, (iv) increase or decrease the Purchase Price for the Existing Notes, and (v) increase or decrease the Maximum
More news about: Republic of Honduras
Jul 14, 2026, 10:16 ET Data Center Rack Market Accelerates with AI Infrastructure Expansion | reach US$ 13.5 billion by 2033 | Persistence Market Research
Asia.Cabinet racks dominate the market with approximately 62% share, owing to their superior security, cable management, and compliance with Tier III and Tier IV data center standards.Rising deployment of AI and high-performance computing workloads is increasing demand for high-density racks
More news about: Persistence Market Research Pvt. Ltd.
Jul 14, 2026, 10:09 ET Lost Money on Insulet Corporation (PODD)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
heightened risk that one or more Insulet products would be found to be in violation of applicable safety regulations and/or pose a risk of injury; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.DEADLINE: August 31, 2026 Shareholders
More news about: The Gross Law Firm
Jul 14, 2026, 10:09 ET Lost Money on First Solar, Inc. (FSLR)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
and attempted relocation of production to the U.S., were likely to negatively impact First Solar's projected performance in the 2026 fiscal year; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.DEADLINE: August 24, 2026 Shareholders
More news about: The Gross Law Firm
Jul 14, 2026, 10:07 ET GRAL UPCOMING DEADLINE : The Gross Law Firm Alerts GRAIL, Inc. Stockholders of Securities Class Action - Contact the Firm
that the probability of achieving the statistical reduction in Stage III & IV cancers by the trial's end had been reduced. On February 19, 2026, GRAIL announced that the "primary endpoint of statistically significant Stage III-IV reduction was not observed" in the NHS-Galleri Trial. The Company attributed
More news about: The Gross Law Firm
Jul 14, 2026, 10:07 ET LCID Deadline Alert: The Gross Law Firm Reminds Lucid Group, Inc. (LCID) Investors of Securities Class Action Deadline on July 28, 2026
deliveries of the Lucid Gravity; (ii) the foregoing was likely to, and did, have a material negative impact on the Company's business and financial results; (iii) accordingly, the defendants had overstated the purported enhancements to Lucid's manufacturing and delivery capabilities and overall operations; and
More news about: The Gross Law Firm
Jul 14, 2026, 10:07 ET ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm
Trio was losing significant market share to a lower priced competing canine parasiticide with broader indicated use in a slowing overall market; and (iii) Zoetis' dermatology products, Apoquel and Cytopoint, were losing substantial market share to a newly launched competing canine treatment.DEADLINE:
More news about: The Gross Law Firm
Jul 14, 2026, 10:07 ET AVAV Shareholder Alert: AeroVironment, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
ongoing efforts to modernize the Satellite Control Network; (ii) accordingly, defendants overstated AeroVironment's business and financial prospects; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.DEADLINE: July 27, 2026 Shareholders
More news about: The Gross Law Firm
Jul 14, 2026, 10:07 ET NNOX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Nano-X Imaging Ltd. Securities Lawsuit - Contact The Gross Law Firm
demand for its products; (ii) in reality, Nano-X's production and manufacturing operations were poorly aligned with demand for the Company's products; (iii) as a result, Nano-X was experiencing significantly increased operating expenses and cash burn; (iv) the foregoing significantly increased the likelihood
More news about: The Gross Law Firm
Jul 14, 2026, 10:07 ET BTGO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in BitGo Holdings, Inc. Securities Lawsuit - Contact The Gross Law Firm
defendants' statements regarding, inter alia, BitGo's financial performance and business prospects as a public company lacked a reasonable basis; and (iii) as a result, the offering documents and defendants' public statements throughout the Class Period were materially false and/or misleading and/or failed
More news about: The Gross Law Firm
Jul 14, 2026, 10:07 ET PICS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in PicS N.V. Securities Lawsuit - Contact The Gross Law Firm
exposures previously classified as Stage 2 to Stage 3, leading to an incremental ECL charge of R$88 million in the three months ended December 31, 2025; (iii) PicS N.V. had experienced a heightened, but unreported, Stage 3 formation rate of more than 7% in the fourth quarter of 2025 that deviated substantially
More news about: The Gross Law Firm
Jul 14, 2026, 10:05 ET Bitmine Immersion Technologies (BMNR) Umumkan Kepemilikan ETH Mencapai 5,77 Juta Token dan Total Kepemilikan Kripto Maupun Total Uang Tunai Sebesar $11,3 Miliar
Bitmine tetap didukung oleh kelompok penting beranggotakan investor institusi seperti Cathie Wood dari ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital, serta investor pribadi Thomas "Tom" Lee guna mendukung tujuan Bitmine untuk mengakuisisi 5% ETH
More news about: Bitmine Immersion Technologies, Inc.
Jul 14, 2026, 09:51 ET 德州南方大學經濟影響報告引用 2023-2024 年數據，指出其對區域經濟每年貢獻 16 億美元
年度，並匯總下列各項的綜合支出效應：大學運作、學生消費、來賓開銷、工程建設、研究活動，以及德州南方畢業生的長期貢獻。在區內就業的校友對大學整體經濟影響的貢獻超過 80%，帶來 13 億美元的額外收入，充分體現德州南方大學教育的長遠價值。校長 J.W. Crawford III 表示：「近一個世紀以來，德州南方大學一直是學生、家庭及社區通向機遇的大門。 這份報告顯示，我們的影響力不只限於課室內。 每位畢業生、每項研究突破及每段合作關係，都在為更強大的勞動隊伍、更具競爭力的經濟，以及人才鼎盛的德州作出貢獻。」報告列出六項主要的經濟影響來源：校友影響力，經由就業參與帶來
More news about: Texas Southern University
Jul 14, 2026, 09:50 ET ADAMA Provides Financial Performance Estimation for the First Half of 2026
ChemChina-Syngenta transaction (non-cash) ii. Amortization of acquisition-related PPA (non-cash) and other acquisition-related costs iii. Capital gain from sale of a subsidiary's logistics center in Israel iv. Restructuring costs (mainly in 2025) v. Fixed asset impairments
More news about: ADAMA Ltd.
Jul 14, 2026, 09:00 ET SPYLT Goes Bananas with Limited-Edition Banana Milk Drop
SPYLT introduced The Flavor Department, a fictional team led by self-proclaimed flavor visionaries Budski McLuckin and Professor Budworth Flavorton III. Instead of a traditional announcement, SPYLT turned to LinkedIn to create fictional job postings and fully developed character profiles designed to
More news about: SPYLT
Jul 14, 2026, 08:01 ET Lexitas Pharma Services and Ocusun Enroll First Patient in a Pilot Study for an Upcoming Phase III Clinical Trial Evaluating Investigational Eye Drop for Age-Related Cataract
The multicenter, randomized, double-masked, placebo-controlled pilot study for the upcoming pivotal phase III study is evaluating the efficacy and safety of ZOC2017217 in participants with age-related cataract. The first patient was enrolled in the study at North
More news about: Lexitas Pharma Services
Jul 14, 2026, 07:50 ET JULY 17, 2026 DEADLINE: Sportradar Group AG (SRAD) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
crucial for Sportradar's operations; (ii) Sportradar's Know-Your-Customer and compliance processes were not as robust as the defendants had claimed; and (iii) as a result, defendants' statements about Sportradar's business, operations, and prospects lacked a reasonable basis.The Sportradar class
More news about: Robbins Geller Rudman & Dowd LLP
Jul 14, 2026, 07:30 ET Zoomcar Cuts Adjusted EBITDA Loss by 47%, Delivers Tenth Consecutive Quarter of Positive Contribution Profit
(9,914,633) Adjusted EBITDA is a non-GAAP financial measure that represents our net income or loss adjusted for (i) depreciation and amortization (ii) finance costs, (iii) Gain on troubled debt restructuring and (iv) Other income/Expense.Contribution Profit/(Loss)The following is the calculation of
More news about: Zoomcar